EXOSOME-MSC Therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EXOSOME-MSC Therapy, covering 2022-02-18 to 2022-02-18. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of EXOSOME-MSC Therapy to Reduce Hyper-inflammation In Moderate COVID-19 Patients [Phase 2, Phase 3]